• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Displaying 39-53 of 40,079 results

No. 90 ORDER denying 77 Motion to Dismiss

Document The NOCO Company v. Deltona Transformer Corporation et al, 6:23-cv-02194, No. 90 (M.D.Fla. Oct. 1, 2024)
Motion to Dismiss (Demurrer)Denied
Thus, to survive a motion to dismiss made pursuant to Rule 12(b)(6), the complaint “must contain sufficient factual matter, accepted as true, to ‘state a claim to relief that is plausible on its face.’” Ashcroft v. Iqbal, 556 U.S. 662, 678 (2009) (quoting Bell Atl.
DTC argues that the Deltran Defendants are separate legal entities and Plaintiff’s claim that overlapping officers or shareholders coupled with DTC’s right to maintain quality control under the trademark license is not “use” under Section 271(a).
Plaintiff further contends that Deltran designs, manufactures, and distributes the Jump Starter products “which incorporate DTC’s know-how, trade secrets, documentation, data, software, and other knowledge, information, and materials controlled by DTC that is part of the Licensed Technology.” (Id. (quoting Doc. 72-23, ¶ 12)).
While the degree of control exerted by DTC over the Deltran Defendants is somewhat opaque, as the court in Garrett astutely noted: “[i]t is hard to imagine a scenario where, prior to discovery, a plaintiff can sufficiently uncover evidence of internal business practices—like in-house testing—for purposes of supporting
all trade secrets, know-how, formulas, prototypes, specifications, directions, instructions, test protocols, procedures, and results, studies, analyses, raw material sources, data, manufacturing data, formulation or production technology, conceptions, ideas, innovation, discoveries, inventions, processes, methods, materials, machines, devices, formulae, equipment, enhancements, modifications, technological developments, techniques, systems, tools, designs, drawings, plans, software, documentation, data, programs and other knowledge, information, skills and materials controlled by Licensor pertaining to the Licensed Products and necessary and/or useful in the manufacture, sale or use of the License Products, and any modifications, variations, derivative works and improvements of or relating to any of the foregoing.
cite Cite Document

No. 18

Document SPACEMAKER SYSTEMS, INC. v. FRAZIER INDUSTRIAL COMPANY, 3:24-cv-09279, No. 18 (D.N.J. Sep. 26, 2024)

cite Cite Document

5 Notice Notice filing date accorded: Notice Notice filing date accorded

Document IPR2024-01219, No. 5 Notice Notice filing date accorded - Notice Notice filing date accorded (P.T.A.B. Sep. 25, 2024)

cite Cite Document

No. 52

Document Fleet Connect Solutions LLC v. Teletrac Navman US Ltd., 2:24-cv-00939, No. 52 (C.D.Cal. Aug. 20, 2024)

cite Cite Document

No. 275

Document In Re: Xarelto (Rivaroxaban) ('310) Patent Litigation, 1:21-md-03017, No. 275 (D.Del. Jun. 21, 2024)

cite Cite Document

No. 52

Document Bayer Intellectual Property Gmbh, et al. v. Auson Pharmaceuticals Inc., et al., 1:23-cv-01103, No. 52 (D.Del. Jun. 21, 2024)

cite Cite Document

No. 66

Document The NOCO Company v. Deltona Transformer Corporation et al, 6:23-cv-02194, No. 66 (M.D.Fla. Jun. 17, 2024)

cite Cite Document

No. 65

Document The NOCO Company v. Deltona Transformer Corporation et al, 6:23-cv-02194, No. 65 (M.D.Fla. Jun. 14, 2024)

cite Cite Document

No. 171

Document Bluestar Genomics v. Song et al, 4:21-cv-04507, No. 171 (N.D.Cal. Jun. 5, 2024)

cite Cite Document

No. 50

Document Bayer Intellectual Property Gmbh, et al. v. Auson Pharmaceuticals Inc., et al., 1:23-cv-01103, No. 50 (D.Del. May. 24, 2024)

cite Cite Document

No. 268

Document In Re: Xarelto (Rivaroxaban) ('310) Patent Litigation, 1:21-md-03017, No. 268 (D.Del. May. 10, 2024)

cite Cite Document

No. 167

Document Bluestar Genomics v. Song et al, 4:21-cv-04507, No. 167 (N.D.Cal. May. 7, 2024)

cite Cite Document

No. 260

Document In Re: Xarelto (Rivaroxaban) ('310) Patent Litigation, 1:21-md-03017, No. 260 (D.Del. Apr. 29, 2024)

cite Cite Document

No. 47

Document Bayer Intellectual Property Gmbh, et al. v. Auson Pharmaceuticals Inc., et al., 1:23-cv-01103, No. 47 (D.Del. Apr. 29, 2024)

cite Cite Document

No. 25

Document HexcelPack, LLC v. Pregis LLC, 1:23-cv-15282, No. 25 (N.D.Ill. Apr. 29, 2024)

cite Cite Document
<< 1 2 3 4 5 6 7 ... >>